로딩 중…
지수 로딩 중…
Belite Bio, Inc
BLTE· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$154.79-2.41%
2026-08-03
Financials
Valuation Metrics
Belite Bio, Inc's Market Cap is $6.20B. At end of 2025 it was $5.36B. Ranked #1235 of 3,112 in US market (top 40%), #407 of 1,445 on NASDAQ (top 28%), #67 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 25%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $6.20B | US#1,235/3,112 Sec#67/269 |
| Revenue | $0.00 | US#2,974/3,112 Sec#204/269 |
| Net Income | $-90M | US—/3,112 Sec—/269 |
| Total Assets | $811M | US#2,534/3,112 Sec#108/269 |
| Net Assets | $796M | US#1,929/3,112 Sec#74/269 |
| Value | ||
| P/B | 7.80x | US#2,476/3,112 Sec#186/269 |
| FCF Yield | -0.00% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROE | -11.34% | US#2,428/3,112 Sec#89/269 |
| ROA | -11.13% | US#2,661/3,112 Sec#103/269 |
| Financial Health | ||
| Debt Ratio | 1.95% | US#19/3,112 Sec#2/269 |
| Total Debt | $0.00 | US—/3,112 Sec—/269 |
| FCF | $-10563.00 | US#2,268/3,112 Sec#85/269 |
| Cash | $0.00 | US—/3,112 Sec—/269 |
| Current Ratio | 33.71x | US#71/3,112 Sec#5/269 |
| Performance | ||
| 1Y Return | 135.53% | US#223/3,112 Sec#63/269 |
| 1M Return | 5.57% | US#903/3,112 Sec#37/269 |
| From 52W High | -22.61% | US#1,841/3,112 Sec#122/269 |
| 1Y MDD | -29.10% | US#1,313/3,112 Sec#82/269 |
| Trading | ||
| Volume | 189,221 shares | US#2,693/3,112 Sec#252/269 |
| Trading Value | $29M | US#1,742/3,112 Sec#119/269 |
| Per Share | ||
| EPS | $-2.31 | US—/3,112 Sec—/269 |
| BPS | $22.97 | US#1,081/3,112 Sec#25/269 |